99mTc‐HYNIC PEGylated Peptide Probe Targeting HER2‐Expression in Breast Cancer
Authors:
- 19 February 2025
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 105 (2) , e70064
Abstract
Increased HER2 expression during breast cancer and its metastatic spread can be checked by specific probes having high affinity towards the target. This study aimed at developing 99mTc‐labelled HER2‐specific molecular probe for accurate detection. The two rL‐A9 peptide variants, HYNIC‐rL‐A9 and HYNIC‐PEG12‐rL‐A9 were manually synthesized by solid phase methodology. 99mTc‐labelling of peptides was accomplished using EDDA and tricine as co‐ligands. [99mTc]Tc‐HYNIC‐rL‐A9 showed poor uptake in HER2‐expressing human breast carcinoma SKBR3 cells whereas the PEGylated counterpart [99mTc]Tc‐HYNIC‐PEG12‐rL‐A9 demonstrated high specific cellular uptake (3.01% ± 0.14%) and low nanomolar binding affinity (Kd = 17.11 ± 7.63 nM). Tumour uptake (SKBR3) of [99mTc]Tc‐HYNIC‐PEG12‐rL‐A9 was higher at 1 and 3 h in comparison to the non‐PEGylated radiopeptide. Blocking studies led to 70% reduction in accumulation of radioactivity in the tumour indicating specificity of the radiopeptide. Introduction of polyethylene glycol (PEG12) as pharmacokinetic modifier led to significantly improved biological profile of the [99mTc]Tc‐HYNIC‐labelled rL‐A9 peptide conjugate.Keywords
This publication has 23 references indexed in Scilit:
- Influence of PEGylation on HER2-targeting retro A9 peptide analogueNuclear Medicine and Biology, 2024
- Design, synthesis and evaluation of 177Lu-labeled inverso and retro-inverso A9 peptide variants targeting HER2-overexpressionBioorganic Chemistry, 2023
- Synthesis and 177Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior VariantBioconjugate Chemistry, 2023
- Targeting HER2-receptors with 177Lu-labeled triazole stapled cyclic peptidomimeticBioorganic Chemistry, 2023
- Peptide Ligands Specifically Targeting HER2 Receptor and the Role Played by a Synthetic Model System of the Receptor Extracellular Domain: Hypothesized Future PerspectivesJournal of Medicinal Chemistry, 2020
- Developing PEGylated Reversed D-Peptide as a Novel HER2-Targeted SPECT Imaging Probe for Breast Cancer DetectionBioconjugate Chemistry, 2020
- An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumorEuropean Journal of Medicinal Chemistry, 2018
- New small 99mTc-labeled peptides for HER2 receptor imagingEuropean Journal of Medicinal Chemistry, 2017
- Unparalleled Contribution of Technetium-99m to Medicine Over 5 DecadesJACC: Cardiovascular Imaging, 2009
- 99mTc-Labeling and in Vitro and in Vivo Evaluation of HYNIC- and (Nα-His)Acetic Acid-Modified [d-Glu1]-MinigastrinBioconjugate Chemistry, 2004